BioSpace News Archive

International research team published initial clinical trial results in Nature Medicine of nine X-Linked Chronic Granulomatous Disease (CGD) patients

Abcam’s new CRISPR-Cas9 knockout cell lines provide reproducible, single gene KOs that support the interrogation of the relationship between genotype and phenotype.

Forbion, a leading European life sciences venture capital firm, announces that Dr. John Montana has joined Forbion as Operating Partner, effective 1st January 2020.

When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-lead research team believes a new approach that inhibits a specific fatty acid binding protein may be the key to halting disease progression.

Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, has announced the pricing of its initial public offering of 9,375,000 shares of its common stock at a price to the public of $17.00 per share.

TCL Electronics Holdings Limited has taken several active measures against the outbreak of Novel Coronavirus.

The Government of Canada will hold a media availability to provide an update on the novel coronavirus.

Geneyork Pharmaceutical announced the U.S. launch and commercial shipment of generic version of Deltasone® Tablets with various strengths 1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg, and 50 mg in collaboration with Lannett Company, Geneyork’s U.S. distribution and marketing partner.